Arrowhead Pharmaceuticals Inc ARWR:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/23/21 EDT
67.75quote price arrow down-0.62 (-0.91%)
Volume
4,956
Close
68.37quote price arrow up+0.45 (+0.66%)
Volume
403,294
52 week range
32.86 - 93.66

...

Loading . . .
  • Open67.97
  • Day High68.63
  • Day Low66.56
  • Prev Close67.92
  • 52 Week High93.66
  • 52 Week High Date06/23/21
  • 52 Week Low32.86
  • 52 Week Low Date09/11/20

Key Stats

  • Market Cap7.116B
  • Shares Out104.08M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-10.9

KEY STATS

  • Open67.97
  • Day High68.63
  • Day Low66.56
  • Prev Close67.92
  • 52 Week High93.66
  • 52 Week High Date06/23/21
  • 52 Week Low32.86
  • 52 Week Low Date09/11/20
  • Market Cap7.116B
  • Shares Out104.08M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-10.9

RATIOS/PROFITABILITY

  • EPS (TTM)-1.07
  • P/E (TTM)-64.08
  • Fwd P/E (NTM)-59.66
  • EBITDA (MRQ)-111.269M
  • ROE (MRQ)-23.33%
  • Revenue (MRQ)89.12M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-122.97%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arrowhead Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more...
Douglass Given M.D., Ph.D.
Chairman
Christopher Anzalone Ph.D.
Chief Executive Officer
Kenneth Myszkowski
Chief Financial Officer
Address
177 E Colorado Blvd, Suite 700
Pasadena, CA
91105
United States

Top Peers

SYMBOLLASTCHG%CHG
XLRN
Acceleron Pharma Inc
122.81+0.60+0.49%
ASND
Ascendis Pharma A/S
115.66-1.69-1.44%
FATE
Fate Therapeutics Inc
86.19+0.23+0.27%
TWST
Twist Bioscience Corp
117.34-4.14-3.41%
PACB
Pacific Biosciences of California Inc
30.35-1.00-3.19%